Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Fatty Acid-Binding Proteins | 28 | 2019 | 296 | 3.850 |
Why?
|
Adipocytes | 31 | 2008 | 1179 | 2.880 |
Why?
|
Insulin Resistance | 40 | 2019 | 3960 | 1.990 |
Why?
|
Endoplasmic Reticulum | 11 | 2010 | 1135 | 1.690 |
Why?
|
Obesity | 58 | 2015 | 12915 | 1.660 |
Why?
|
Adipose Tissue | 40 | 2009 | 3293 | 1.560 |
Why?
|
Tumor Necrosis Factor-alpha | 31 | 2009 | 4357 | 1.540 |
Why?
|
Receptors, Tumor Necrosis Factor | 18 | 2003 | 584 | 1.190 |
Why?
|
Metabolic Diseases | 5 | 2017 | 685 | 1.150 |
Why?
|
Inflammation | 23 | 2017 | 10757 | 0.970 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 6 | 2008 | 444 | 0.950 |
Why?
|
Carrier Proteins | 13 | 2005 | 4938 | 0.800 |
Why?
|
Insulin | 28 | 2013 | 6592 | 0.790 |
Why?
|
Lipid Metabolism | 16 | 2015 | 1902 | 0.740 |
Why?
|
Stress, Physiological | 8 | 2010 | 1395 | 0.710 |
Why?
|
Propionates | 1 | 2019 | 182 | 0.620 |
Why?
|
Glucose | 16 | 2017 | 4361 | 0.610 |
Why?
|
Macrophages | 15 | 2015 | 5745 | 0.570 |
Why?
|
Neoplasm Proteins | 11 | 2015 | 3613 | 0.570 |
Why?
|
Glucagon | 1 | 2019 | 532 | 0.560 |
Why?
|
Mitogen-Activated Protein Kinase 8 | 5 | 2008 | 74 | 0.530 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2013 | 12281 | 0.530 |
Why?
|
Leptin | 14 | 2015 | 1590 | 0.520 |
Why?
|
Myelin P2 Protein | 3 | 2000 | 20 | 0.500 |
Why?
|
Animals | 88 | 2019 | 167940 | 0.490 |
Why?
|
Arteriosclerosis | 6 | 2005 | 1064 | 0.480 |
Why?
|
Mice | 65 | 2019 | 81216 | 0.460 |
Why?
|
Receptor, Insulin | 11 | 2008 | 836 | 0.450 |
Why?
|
Proteins | 12 | 2008 | 6030 | 0.430 |
Why?
|
GATA3 Transcription Factor | 4 | 2007 | 152 | 0.420 |
Why?
|
Adiponectin | 6 | 2006 | 1115 | 0.420 |
Why?
|
Phenylbutyrates | 3 | 2008 | 72 | 0.410 |
Why?
|
Hormones, Ectopic | 2 | 2003 | 37 | 0.410 |
Why?
|
Cell Differentiation | 10 | 2007 | 11480 | 0.410 |
Why?
|
GATA2 Transcription Factor | 4 | 2005 | 158 | 0.400 |
Why?
|
Mice, Obese | 11 | 2015 | 420 | 0.400 |
Why?
|
Diabetes Mellitus | 10 | 2015 | 5884 | 0.390 |
Why?
|
Fatty Acids, Monounsaturated | 2 | 2013 | 190 | 0.390 |
Why?
|
Liver | 11 | 2013 | 7512 | 0.380 |
Why?
|
Immunity | 1 | 2017 | 998 | 0.380 |
Why?
|
Energy Metabolism | 3 | 2019 | 2869 | 0.380 |
Why?
|
Unfolded Protein Response | 2 | 2010 | 233 | 0.380 |
Why?
|
Thiazolidinediones | 3 | 2009 | 465 | 0.350 |
Why?
|
Taurochenodeoxycholic Acid | 2 | 2007 | 35 | 0.340 |
Why?
|
Atherosclerosis | 6 | 2013 | 3524 | 0.340 |
Why?
|
Mitogen-Activated Protein Kinase 9 | 2 | 2006 | 31 | 0.330 |
Why?
|
Trans-Activators | 3 | 2005 | 2861 | 0.330 |
Why?
|
Overnutrition | 1 | 2008 | 25 | 0.320 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 12 | 2006 | 256 | 0.320 |
Why?
|
Adipose Tissue, Brown | 3 | 2005 | 755 | 0.320 |
Why?
|
Mice, Inbred C57BL | 25 | 2019 | 22025 | 0.310 |
Why?
|
Nerve Tissue Proteins | 5 | 2002 | 4409 | 0.300 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2006 | 130 | 0.300 |
Why?
|
Antigens, CD | 10 | 2003 | 4002 | 0.300 |
Why?
|
Homeostasis | 12 | 2008 | 3305 | 0.290 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2013 | 1314 | 0.270 |
Why?
|
Mice, Knockout | 19 | 2015 | 14396 | 0.270 |
Why?
|
Fatty Acids | 6 | 2006 | 1805 | 0.270 |
Why?
|
Adipogenesis | 2 | 2006 | 358 | 0.260 |
Why?
|
Intercellular Signaling Peptides and Proteins | 5 | 2005 | 1655 | 0.260 |
Why?
|
Transcription Factors | 7 | 2008 | 12100 | 0.260 |
Why?
|
Signal Transduction | 18 | 2017 | 23363 | 0.260 |
Why?
|
Mammary Glands, Human | 1 | 2007 | 204 | 0.250 |
Why?
|
Mammary Glands, Animal | 1 | 2007 | 265 | 0.250 |
Why?
|
Cholesterol | 5 | 2007 | 2925 | 0.250 |
Why?
|
PPAR gamma | 2 | 2005 | 484 | 0.250 |
Why?
|
Hormones | 1 | 2008 | 867 | 0.240 |
Why?
|
Lipolysis | 3 | 2000 | 211 | 0.240 |
Why?
|
Mitogen-Activated Protein Kinases | 3 | 2004 | 1246 | 0.230 |
Why?
|
DNA-Binding Proteins | 5 | 2005 | 9590 | 0.230 |
Why?
|
Gene Expression Regulation | 12 | 2012 | 11902 | 0.230 |
Why?
|
Apoptosis | 6 | 2012 | 9497 | 0.230 |
Why?
|
Cell Lineage | 3 | 2015 | 2525 | 0.230 |
Why?
|
Triglycerides | 8 | 2013 | 2476 | 0.230 |
Why?
|
Glucose Tolerance Test | 6 | 2006 | 1174 | 0.230 |
Why?
|
Tumor Suppressor Proteins | 4 | 2008 | 2804 | 0.220 |
Why?
|
Hypothalamus | 1 | 2008 | 998 | 0.220 |
Why?
|
Blood Glucose | 8 | 2008 | 6375 | 0.210 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 3 | 2005 | 854 | 0.210 |
Why?
|
Food | 2 | 2007 | 772 | 0.210 |
Why?
|
Insulin Receptor Substrate Proteins | 6 | 2008 | 557 | 0.210 |
Why?
|
Metabolic Networks and Pathways | 1 | 2007 | 788 | 0.210 |
Why?
|
Hypertriglyceridemia | 1 | 2006 | 316 | 0.210 |
Why?
|
Gene Expression | 6 | 2006 | 7592 | 0.200 |
Why?
|
Apolipoproteins E | 5 | 2007 | 1437 | 0.200 |
Why?
|
Mice, Transgenic | 11 | 2009 | 9531 | 0.190 |
Why?
|
Receptors, Tumor Necrosis Factor, Type II | 8 | 2006 | 346 | 0.190 |
Why?
|
eIF-2 Kinase | 3 | 2008 | 144 | 0.190 |
Why?
|
Cytokines | 4 | 2017 | 7345 | 0.190 |
Why?
|
Cell Line | 11 | 2008 | 15626 | 0.190 |
Why?
|
Protein Folding | 3 | 2010 | 867 | 0.180 |
Why?
|
Fatty Liver | 1 | 2006 | 777 | 0.180 |
Why?
|
Organ Specificity | 3 | 2017 | 1955 | 0.170 |
Why?
|
Phosphorylation | 9 | 2006 | 8314 | 0.170 |
Why?
|
Membrane Proteins | 4 | 2007 | 7854 | 0.170 |
Why?
|
Blotting, Northern | 5 | 2005 | 1544 | 0.170 |
Why?
|
Lipids | 8 | 2013 | 3336 | 0.170 |
Why?
|
RNA, Messenger | 15 | 2009 | 12762 | 0.170 |
Why?
|
Glycogen | 1 | 2019 | 251 | 0.160 |
Why?
|
Mice, Mutant Strains | 4 | 2007 | 1760 | 0.150 |
Why?
|
Interleukin-6 | 7 | 2007 | 3207 | 0.140 |
Why?
|
Phosphoproteins | 5 | 2004 | 2441 | 0.140 |
Why?
|
Neovascularization, Physiologic | 2 | 2015 | 1335 | 0.140 |
Why?
|
Stearoyl-CoA Desaturase | 2 | 2008 | 85 | 0.140 |
Why?
|
Humans | 61 | 2019 | 760261 | 0.140 |
Why?
|
Cells, Cultured | 9 | 2012 | 18968 | 0.140 |
Why?
|
Cell Communication | 2 | 2017 | 1642 | 0.130 |
Why?
|
Biological Evolution | 2 | 2017 | 1074 | 0.130 |
Why?
|
3T3 Cells | 6 | 2006 | 1085 | 0.130 |
Why?
|
Adenylate Kinase | 2 | 2006 | 102 | 0.130 |
Why?
|
Body Composition | 2 | 2003 | 2418 | 0.130 |
Why?
|
Body Weight | 6 | 2006 | 4613 | 0.130 |
Why?
|
Promoter Regions, Genetic | 5 | 2006 | 5784 | 0.130 |
Why?
|
Receptors, Adrenergic, beta | 3 | 2001 | 241 | 0.130 |
Why?
|
I-kappa B Kinase | 2 | 2008 | 251 | 0.130 |
Why?
|
Polymorphism, Genetic | 1 | 2006 | 4286 | 0.130 |
Why?
|
Hypercholesterolemia | 1 | 2002 | 1155 | 0.130 |
Why?
|
Mast Cells | 2 | 2015 | 1428 | 0.130 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2003 | 280 | 0.120 |
Why?
|
Ethylene Glycols | 1 | 1996 | 190 | 0.120 |
Why?
|
Cryoprotective Agents | 1 | 1996 | 129 | 0.120 |
Why?
|
Epithelial Cells | 1 | 2007 | 3665 | 0.120 |
Why?
|
Cell Membrane | 3 | 2002 | 3683 | 0.120 |
Why?
|
Organ Size | 3 | 2004 | 2249 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 4 | 2006 | 4573 | 0.120 |
Why?
|
Models, Biological | 5 | 2008 | 9468 | 0.110 |
Why?
|
Adaptive Immunity | 1 | 2017 | 724 | 0.100 |
Why?
|
Weight Gain | 2 | 2019 | 2347 | 0.100 |
Why?
|
Muscle Proteins | 1 | 1997 | 1152 | 0.100 |
Why?
|
Immune System | 1 | 2017 | 795 | 0.100 |
Why?
|
Stem Cell Factor | 1 | 2012 | 198 | 0.100 |
Why?
|
Bone Marrow Transplantation | 3 | 2008 | 2696 | 0.100 |
Why?
|
Resistin | 2 | 2003 | 172 | 0.090 |
Why?
|
Oocytes | 1 | 1996 | 1165 | 0.090 |
Why?
|
Cytoskeleton | 1 | 1996 | 1167 | 0.090 |
Why?
|
Cryopreservation | 1 | 1996 | 720 | 0.090 |
Why?
|
Nerve Growth Factor | 2 | 2003 | 158 | 0.090 |
Why?
|
Male | 39 | 2019 | 359413 | 0.090 |
Why?
|
Thinness | 3 | 2006 | 491 | 0.090 |
Why?
|
Aorta | 4 | 2015 | 2042 | 0.090 |
Why?
|
Inflammation Mediators | 2 | 2017 | 1882 | 0.090 |
Why?
|
Immunoblotting | 2 | 2005 | 1649 | 0.090 |
Why?
|
Dietary Fats | 3 | 2013 | 1992 | 0.090 |
Why?
|
Receptors, Adrenergic, beta-3 | 2 | 2000 | 62 | 0.090 |
Why?
|
Muscle, Skeletal | 5 | 2008 | 4923 | 0.090 |
Why?
|
Blotting, Western | 6 | 2012 | 5039 | 0.090 |
Why?
|
Multiprotein Complexes | 2 | 2008 | 1120 | 0.090 |
Why?
|
Protein Isoforms | 2 | 2006 | 1697 | 0.090 |
Why?
|
Chemokine CXCL5 | 1 | 2009 | 28 | 0.080 |
Why?
|
Retinopathy of Prematurity | 1 | 2014 | 432 | 0.080 |
Why?
|
Dairy Products | 1 | 2013 | 494 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2005 | 1531 | 0.080 |
Why?
|
Cromolyn Sodium | 1 | 2009 | 77 | 0.080 |
Why?
|
Rats | 5 | 2005 | 23695 | 0.080 |
Why?
|
HIV-1 | 1 | 2006 | 6850 | 0.080 |
Why?
|
Diet | 7 | 2013 | 8008 | 0.080 |
Why?
|
Transcription, Genetic | 5 | 2006 | 7593 | 0.070 |
Why?
|
Hyperinsulinism | 3 | 2008 | 398 | 0.070 |
Why?
|
Ligands | 2 | 2008 | 3277 | 0.070 |
Why?
|
Body Fat Distribution | 1 | 2008 | 243 | 0.070 |
Why?
|
Mutation | 8 | 2007 | 29950 | 0.070 |
Why?
|
Lipogenesis | 1 | 2008 | 210 | 0.070 |
Why?
|
3T3-L1 Cells | 1 | 2007 | 209 | 0.070 |
Why?
|
C-Reactive Protein | 4 | 2007 | 3822 | 0.070 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 1 | 2007 | 165 | 0.070 |
Why?
|
Female | 26 | 2019 | 391011 | 0.060 |
Why?
|
Chemokine CCL2 | 1 | 2008 | 607 | 0.060 |
Why?
|
Receptors, HIV | 1 | 2006 | 159 | 0.060 |
Why?
|
Multiple Birth Offspring | 1 | 2005 | 22 | 0.060 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2006 | 180 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2009 | 729 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2017 | 3046 | 0.060 |
Why?
|
HIV-Associated Lipodystrophy Syndrome | 1 | 2006 | 138 | 0.060 |
Why?
|
Orphan Nuclear Receptors | 1 | 2005 | 63 | 0.060 |
Why?
|
Tunicamycin | 1 | 2004 | 108 | 0.060 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2005 | 102 | 0.060 |
Why?
|
NF-kappa B | 2 | 2005 | 2486 | 0.060 |
Why?
|
Recombinant Fusion Proteins | 2 | 2005 | 3735 | 0.060 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2006 | 459 | 0.060 |
Why?
|
Mitochondrial Proteins | 2 | 2000 | 979 | 0.060 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 318 | 0.060 |
Why?
|
Body Mass Index | 9 | 2005 | 12901 | 0.060 |
Why?
|
Mesentery | 1 | 2004 | 203 | 0.060 |
Why?
|
Luciferases | 1 | 2005 | 716 | 0.060 |
Why?
|
Reference Values | 4 | 2003 | 4920 | 0.060 |
Why?
|
Genes, Tumor Suppressor | 1 | 2008 | 1056 | 0.060 |
Why?
|
Tissue Distribution | 2 | 2005 | 2262 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2005 | 514 | 0.050 |
Why?
|
Protein Binding | 2 | 2006 | 9336 | 0.050 |
Why?
|
CD40 Ligand | 1 | 2005 | 522 | 0.050 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2009 | 1109 | 0.050 |
Why?
|
Mice, Congenic | 1 | 2002 | 97 | 0.050 |
Why?
|
Cardiovascular Diseases | 2 | 2006 | 15740 | 0.050 |
Why?
|
Immunosorbent Techniques | 1 | 2002 | 176 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 600 | 0.050 |
Why?
|
Phenotype | 3 | 2006 | 16543 | 0.050 |
Why?
|
Biphenyl Compounds | 1 | 2007 | 988 | 0.050 |
Why?
|
Endothelium, Vascular | 2 | 2012 | 4437 | 0.050 |
Why?
|
Enzyme Activation | 2 | 2006 | 3604 | 0.050 |
Why?
|
CHO Cells | 1 | 2005 | 1389 | 0.050 |
Why?
|
Microscopy, Electron | 1 | 2005 | 2558 | 0.050 |
Why?
|
Tyrosine | 3 | 2001 | 1440 | 0.050 |
Why?
|
Base Sequence | 2 | 2006 | 12447 | 0.050 |
Why?
|
Diet, Fat-Restricted | 1 | 2004 | 330 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 908 | 0.050 |
Why?
|
Premenopause | 2 | 1997 | 1039 | 0.050 |
Why?
|
Crosses, Genetic | 1 | 2003 | 751 | 0.050 |
Why?
|
Blood Specimen Collection | 1 | 2003 | 238 | 0.050 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2007 | 825 | 0.050 |
Why?
|
Isoenzymes | 1 | 2006 | 1690 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2006 | 1173 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2002 | 778 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2005 | 666 | 0.050 |
Why?
|
Disease Models, Animal | 4 | 2006 | 18134 | 0.050 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2005 | 600 | 0.050 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2007 | 975 | 0.050 |
Why?
|
Precipitin Tests | 1 | 2002 | 815 | 0.050 |
Why?
|
Benzophenones | 1 | 2001 | 58 | 0.050 |
Why?
|
Indicators and Reagents | 1 | 2002 | 461 | 0.050 |
Why?
|
Cricetinae | 1 | 2005 | 2427 | 0.050 |
Why?
|
Myeloid Cells | 1 | 2006 | 821 | 0.050 |
Why?
|
Chemotaxis | 2 | 2015 | 598 | 0.050 |
Why?
|
Protein Biosynthesis | 2 | 1999 | 2104 | 0.050 |
Why?
|
Cell Adhesion Molecules | 1 | 2007 | 1602 | 0.050 |
Why?
|
Uncoupling Agents | 1 | 2000 | 46 | 0.050 |
Why?
|
Haptoglobins | 1 | 2002 | 167 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1548 | 0.050 |
Why?
|
ADAM Proteins | 1 | 2002 | 240 | 0.050 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2005 | 498 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 2002 | 394 | 0.040 |
Why?
|
HIV Infections | 2 | 2006 | 17159 | 0.040 |
Why?
|
Hepatocytes | 1 | 2007 | 1228 | 0.040 |
Why?
|
Biological Transport | 1 | 2005 | 2087 | 0.040 |
Why?
|
Nutritional Status | 1 | 2008 | 1606 | 0.040 |
Why?
|
Gastric Bypass | 1 | 2008 | 826 | 0.040 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2003 | 542 | 0.040 |
Why?
|
Genetic Markers | 1 | 2006 | 2608 | 0.040 |
Why?
|
Hypoglycemic Agents | 2 | 2004 | 3149 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2449 | 0.040 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2004 | 396 | 0.040 |
Why?
|
Binding Sites | 1 | 2008 | 6050 | 0.040 |
Why?
|
Eating | 2 | 2006 | 1538 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2006 | 16905 | 0.040 |
Why?
|
Drug Interactions | 1 | 2004 | 1426 | 0.040 |
Why?
|
In Situ Nick-End Labeling | 1 | 2000 | 613 | 0.040 |
Why?
|
Leukocytes, Mononuclear | 1 | 2006 | 1828 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2006 | 1890 | 0.040 |
Why?
|
Lymphocyte Activation | 2 | 2007 | 5498 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2008 | 2058 | 0.040 |
Why?
|
Oxygen | 2 | 2014 | 4189 | 0.040 |
Why?
|
Dendritic Cells | 2 | 2007 | 2730 | 0.040 |
Why?
|
Ion Channels | 2 | 2000 | 1043 | 0.040 |
Why?
|
Social Behavior | 1 | 2005 | 1130 | 0.040 |
Why?
|
Lipoproteins, HDL | 1 | 2003 | 667 | 0.040 |
Why?
|
Vascular Diseases | 1 | 2007 | 1180 | 0.040 |
Why?
|
Zinc Fingers | 1 | 2000 | 568 | 0.040 |
Why?
|
Life Style | 4 | 2005 | 3888 | 0.040 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1694 | 0.040 |
Why?
|
Up-Regulation | 3 | 2002 | 4127 | 0.040 |
Why?
|
Asthma | 2 | 2007 | 6167 | 0.040 |
Why?
|
Models, Molecular | 1 | 2008 | 5429 | 0.040 |
Why?
|
Neurons | 2 | 2008 | 9416 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2006 | 1894 | 0.040 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2008 | 2895 | 0.040 |
Why?
|
Cloning, Molecular | 1 | 2003 | 4172 | 0.040 |
Why?
|
Glucose Transporter Type 4 | 1 | 1997 | 240 | 0.040 |
Why?
|
Time Factors | 5 | 2006 | 40133 | 0.040 |
Why?
|
Blood Pressure | 1 | 2013 | 8523 | 0.040 |
Why?
|
Hypersensitivity | 1 | 2006 | 1159 | 0.040 |
Why?
|
Body Temperature | 1 | 2000 | 777 | 0.040 |
Why?
|
Absorptiometry, Photon | 1 | 2003 | 1731 | 0.030 |
Why?
|
Longevity | 1 | 2004 | 1050 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2008 | 3107 | 0.030 |
Why?
|
Actins | 3 | 2002 | 2049 | 0.030 |
Why?
|
Pyrazoles | 1 | 2007 | 1992 | 0.030 |
Why?
|
Molecular Sequence Data | 2 | 2007 | 17628 | 0.030 |
Why?
|
Odds Ratio | 2 | 2006 | 9712 | 0.030 |
Why?
|
Ethylene Glycol | 1 | 1996 | 31 | 0.030 |
Why?
|
Cold Temperature | 1 | 2000 | 780 | 0.030 |
Why?
|
Regression Analysis | 2 | 1997 | 6361 | 0.030 |
Why?
|
Cyclic AMP | 1 | 2000 | 1455 | 0.030 |
Why?
|
Kinetics | 1 | 2004 | 6378 | 0.030 |
Why?
|
Rats, Zucker | 1 | 1996 | 132 | 0.030 |
Why?
|
Sphingomyelin Phosphodiesterase | 1 | 1996 | 82 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2001 | 3086 | 0.030 |
Why?
|
Middle Aged | 17 | 2013 | 220175 | 0.030 |
Why?
|
PPAR delta | 1 | 2015 | 40 | 0.030 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1997 | 440 | 0.030 |
Why?
|
Prospective Studies | 8 | 2013 | 54263 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2004 | 6226 | 0.030 |
Why?
|
Exercise | 2 | 2003 | 5783 | 0.030 |
Why?
|
Feces | 1 | 2002 | 1466 | 0.030 |
Why?
|
Cytoprotection | 1 | 2015 | 200 | 0.030 |
Why?
|
DNA Primers | 1 | 1999 | 2819 | 0.030 |
Why?
|
Gene Deletion | 1 | 2002 | 2668 | 0.030 |
Why?
|
Models, Genetic | 1 | 2005 | 3442 | 0.030 |
Why?
|
Protein Structure, Tertiary | 1 | 2001 | 3800 | 0.030 |
Why?
|
Myocardial Ischemia | 1 | 2005 | 2161 | 0.030 |
Why?
|
Membrane Transport Proteins | 1 | 2000 | 1036 | 0.030 |
Why?
|
Islets of Langerhans | 1 | 2000 | 1341 | 0.030 |
Why?
|
Adult | 14 | 2006 | 219847 | 0.030 |
Why?
|
Interleukin-12 | 2 | 2006 | 584 | 0.030 |
Why?
|
Cell Survival | 2 | 2015 | 5796 | 0.030 |
Why?
|
Down-Regulation | 1 | 2001 | 2918 | 0.030 |
Why?
|
Thiazoles | 1 | 2001 | 1509 | 0.030 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2003 | 1387 | 0.030 |
Why?
|
Pancreas | 1 | 2000 | 1677 | 0.030 |
Why?
|
Hydrogenation | 1 | 2013 | 20 | 0.030 |
Why?
|
Adaptation, Physiological | 1 | 2000 | 1297 | 0.030 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2006 | 4355 | 0.030 |
Why?
|
Gene Targeting | 1 | 1996 | 839 | 0.030 |
Why?
|
Cohort Studies | 5 | 2007 | 41317 | 0.030 |
Why?
|
Disease Progression | 2 | 2007 | 13505 | 0.030 |
Why?
|
T-Lymphocytes | 2 | 2007 | 10183 | 0.030 |
Why?
|
Serine | 1 | 1996 | 831 | 0.020 |
Why?
|
Trans Fatty Acids | 1 | 2013 | 155 | 0.020 |
Why?
|
Genotype | 1 | 2006 | 12959 | 0.020 |
Why?
|
Weight Loss | 1 | 2002 | 2683 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2003 | 3185 | 0.020 |
Why?
|
DNA | 1 | 2005 | 7236 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2001 | 2978 | 0.020 |
Why?
|
Cell Death | 1 | 2015 | 1670 | 0.020 |
Why?
|
C-Peptide | 2 | 2003 | 433 | 0.020 |
Why?
|
Interleukin-1 | 2 | 2006 | 1250 | 0.020 |
Why?
|
Sex Characteristics | 1 | 2000 | 2627 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2004 | 5793 | 0.020 |
Why?
|
Diet, Atherogenic | 1 | 2009 | 93 | 0.020 |
Why?
|
Receptors, Leptin | 2 | 2001 | 350 | 0.020 |
Why?
|
Radioimmunoassay | 2 | 2001 | 866 | 0.020 |
Why?
|
Case-Control Studies | 5 | 2007 | 22041 | 0.020 |
Why?
|
Phospholipids | 1 | 2013 | 789 | 0.020 |
Why?
|
Microscopy, Fluorescence | 1 | 1996 | 2651 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2008 | 263 | 0.020 |
Why?
|
Retinal Vessels | 1 | 2014 | 836 | 0.020 |
Why?
|
Fluorescent Dyes | 1 | 1996 | 1914 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6543 | 0.020 |
Why?
|
Anthropometry | 2 | 2004 | 1348 | 0.020 |
Why?
|
Stem Cells | 1 | 2000 | 3525 | 0.020 |
Why?
|
Thrombosis | 1 | 2001 | 3052 | 0.020 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 2006 | 514 | 0.020 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2006 | 95 | 0.020 |
Why?
|
I-kappa B Proteins | 1 | 2006 | 212 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 2006 | 413 | 0.020 |
Why?
|
Child, Preschool | 1 | 2008 | 42034 | 0.020 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2006 | 330 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2008 | 13629 | 0.020 |
Why?
|
E-Selectin | 1 | 2007 | 576 | 0.020 |
Why?
|
Aging | 2 | 2001 | 8641 | 0.010 |
Why?
|
Cross-Sectional Studies | 5 | 2005 | 25928 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 694 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 17766 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2009 | 1346 | 0.010 |
Why?
|
Risk Factors | 6 | 2013 | 74269 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2008 | 39254 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2641 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2006 | 877 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2006 | 825 | 0.010 |
Why?
|
Quality of Life | 1 | 2005 | 13300 | 0.010 |
Why?
|
RNA Interference | 1 | 2012 | 2846 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2013 | 2422 | 0.010 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2007 | 1128 | 0.010 |
Why?
|
Psychology | 1 | 2005 | 355 | 0.010 |
Why?
|
Respiratory Mucosa | 1 | 2006 | 441 | 0.010 |
Why?
|
Aged | 8 | 2013 | 168995 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2004 | 11891 | 0.010 |
Why?
|
Interleukin-4 | 1 | 2006 | 1133 | 0.010 |
Why?
|
Bronchi | 1 | 2006 | 848 | 0.010 |
Why?
|
Clenbuterol | 1 | 2001 | 9 | 0.010 |
Why?
|
Organic Anion Transporters | 1 | 2002 | 100 | 0.010 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2003 | 227 | 0.010 |
Why?
|
Antigen Presentation | 1 | 2007 | 1254 | 0.010 |
Why?
|
Dobutamine | 1 | 2001 | 116 | 0.010 |
Why?
|
Dioxoles | 1 | 2001 | 95 | 0.010 |
Why?
|
Isoproterenol | 1 | 2001 | 394 | 0.010 |
Why?
|
Cholesterol Esters | 1 | 2001 | 73 | 0.010 |
Why?
|
Eicosanoids | 1 | 2003 | 278 | 0.010 |
Why?
|
Foam Cells | 1 | 2001 | 68 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2006 | 1201 | 0.010 |
Why?
|
Th2 Cells | 1 | 2006 | 1048 | 0.010 |
Why?
|
Adrenergic alpha-Agonists | 1 | 2001 | 178 | 0.010 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2001 | 173 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2006 | 2222 | 0.010 |
Why?
|
Adrenergic beta-Agonists | 1 | 2001 | 345 | 0.010 |
Why?
|
Embryo, Mammalian | 1 | 2006 | 1667 | 0.010 |
Why?
|
Food Deprivation | 1 | 2000 | 114 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2015 | 10434 | 0.010 |
Why?
|
COS Cells | 1 | 2001 | 1129 | 0.010 |
Why?
|
Solubility | 1 | 2001 | 1088 | 0.010 |
Why?
|
Glycoproteins | 1 | 2007 | 2208 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2005 | 12156 | 0.010 |
Why?
|
Hyperphagia | 1 | 2000 | 138 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2005 | 2932 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2007 | 21065 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2012 | 3537 | 0.010 |
Why?
|
Menopause | 1 | 2007 | 1640 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 2424 | 0.010 |
Why?
|
Norepinephrine | 1 | 2001 | 900 | 0.010 |
Why?
|
Spinal Cord | 1 | 2007 | 1817 | 0.010 |
Why?
|
Neoplasms | 1 | 2008 | 22066 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2006 | 1663 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2006 | 4900 | 0.010 |
Why?
|
Postmenopause | 1 | 2007 | 2503 | 0.010 |
Why?
|
Energy Intake | 1 | 2003 | 2128 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2007 | 13456 | 0.010 |
Why?
|
Fibroblasts | 1 | 2006 | 4091 | 0.010 |
Why?
|
Ceramides | 1 | 1996 | 200 | 0.010 |
Why?
|
Risk | 1 | 2007 | 9629 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2007 | 5120 | 0.010 |
Why?
|
United States | 3 | 2013 | 72363 | 0.010 |
Why?
|
Temperature | 1 | 1999 | 2221 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2002 | 3731 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 1999 | 1956 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2005 | 7803 | 0.010 |
Why?
|
Biopsy | 1 | 2001 | 6775 | 0.010 |
Why?
|
Health Personnel | 1 | 2003 | 3310 | 0.010 |
Why?
|
Sex Factors | 1 | 2003 | 10530 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2005 | 15273 | 0.000 |
Why?
|
Smoking | 1 | 2001 | 9070 | 0.000 |
Why?
|
Brain | 1 | 2007 | 26912 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2001 | 58947 | 0.000 |
Why?
|